Kerala Ayurveda Peer Comparison

Kerala Ayurveda Ltd. lags significantly behind its peers in several key financial metrics, particularly in profitability with negative EPS and ROE, and high debt levels. The company’s growth prospects are overshadowed by its poor financial health, making it a less attractive option compared to its sector peers who display stronger profitability and robust financial structures.

• • Kerala Ayurveda Ltd. shows negative EPS and ROE, indicating poor profitability.
• • High debt-equity ratio at 2.40 suggests financial risk compared to peers.
• • Growth metrics are decent but overshadowed by profitability concerns.

• • Dr. Reddy's Laboratories Ltd.: Highest profitability with strong EPS and ROE.
• • Cipla Ltd.: Strong balance sheet with low debt and solid growth metrics.
• • Mankind Pharma Ltd.: Outstanding revenue growth and solid margins.
• • Sun Pharmaceutical Industries Ltd.: Strong profitability metrics despite high PE.
• • Torrent Pharmaceuticals Ltd.: Balanced approach with good profitability and manageable debt.